No Data
No Data
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology
Is Weakness In Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Insider Sale: Chief Medical Officer of $PTGX (PTGX) Sells 16,000 Shares
Protagonist Therapeutics(PTGX.US) Officer Sells US$5.64 Million in Common Stock
Protagonist Therapeutics(PTGX.US) Officer Sells US$4.68 Million in Common Stock
Express News | Form 144 | Protagonist Therapeutics(PTGX.US) Officer Proposes to Sell 4.81 Million in Common Stocks